IL-10 Reporter HEK 293 Cells

STAT3-SEAP reporter cells

HEK-Blue™ IL-10 Cells

$1,584
*Save on additional vials when you buy the matching cell reference.

Note: A new clone is provided with an improved IL-10 response. The cat code has been changed accordingly (hkb-il10v2).

SPECIFICATIONS

Specifications

Target

IL-10

Target species

Human, Mouse

Tested applications

Detection and quantification of IL-10 activity

Cell type
Epithelial
Growth properties
Adherent
Tissue origin
Human embryonic kidney cells
Reporter gene
SEAP
Detection method
Colorimetric
Detection range

Human IL-10: 0.3 - 30 ng/ml 
Mouse IL-10: 25 - 1000 ng/ml

Growth medium

Complete DMEM (see TDS)

Antibiotic resistance
Blasticidin
Hygromycin
Zeocin®
Mycoplasma-free

Verified using Plasmotest™

Quality control

Each lot is functionally tested and validated.

CONTENTS

Contents

  • Product: 
    HEK-Blue™ IL-10 Cells
  • Cat code: 
    hkb-il10v2
  • Quantity: 
    3-7 x 10^6 cells
Includes:
  • 2 x 1 ml of HEK-Blue™ Selection (250x concentrate)
  • 1 ml of Normocin™ (50 mg/ml)
  • 1 ml of QB reagent and 1 ml of QB buffer (sufficient to prepare 100 ml of QUANTI-Blue™ Solution, a SEAP detection reagent)

Shipping & Storage

  • Shipping method:  Dry ice
  • Storage:

    • Liquid nitrogen vapor
    Stability: 20 passages

    Caution:

    • Upon receipt, store immediately in liquid nitrogen vapor. Do not store cell vials at -80°C.

Details

Interleukin 10 (IL-10), is the founding member of the IL-10 cytokine family, which comprises IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28A (IFN-λ2), IL-28B (IFN-λ3), and IL-29 (IFN-λ1)1. IL-10 was originally depicted as a key mediator of anti-inflammatory responses. While the immunosuppressive action of IL-10 is illustrated by its genetic association to inflammatory bowel disease, or its upregulated expression in chronic infections, an unanticipated IL-10 protective role has been reported in cancer [1].
IL-10 also plays important homeostatic roles in non-immune cells, including neurons, adipocytes, and epithelial cells [1]. The manipulation of IL-10 production and signaling has thus become an attractive therapeutic strategy [2].
Upon IL-10 binding, the IL-10Rα chain oligomerizes with the IL-10Rβ chain. This in turn allows the phosphorylation of JAK1 (Janus kinase 1) and TyK2 (Tyrosine kinase 2), and the subsequent activation of STAT3 (Signal transducer and activator of transcription 3) [1]. Importantly, STAT3 is also activated downstream of other cytokine receptors. How the cells trigger distinct and specific gene expression in response to cytokines signaling through the same transcription factor is not fully understood yet [1].

 

1. Saraiva M, et al., 2019. Biology and therapeutic potential of interleukin-10. J.  Exp. Med. doi: 10.1084/jem.20190418.
2. Ouyang W & O’Garra A, 2019. IL-10 family cytokines IL-10 and IL-22: from basic science to clinical translation. Immunity. 50:871-91.

CUSTOMER SERVICE & TECHNICAL SUPPORT

Question about this product ?